$NVEC

NVE CORP /NEW/ (NVEC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.07 Submission of Matters to a Vote of Security Holders. Our 2026 Annual Meeting of Shareholders was held August 6, 2026, for the following purposes: (1) elect seven directors; (2) advisory approval of named executive officer compensation; and (3) ratify the selection of Bo

Original reporting
Published Aug 10, 2026, 8:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$NVEC
Neutral
medium confidence
Mentioned
$NVEC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NVECNeutralLow
01

Why it matters

The company reports CEO succession: Daniel A. Baker retired as president and CEO effective at the meeting; Dr. Baker was re-elected to the board and named chairman; Peter G. Eames was elected to the board and appointed president and CEO. The board expanded from five to seven directors with the election of Carolyn W. Valentine.

02

Market read

This is a governance and leadership transition disclosure that may affect near-term sentiment, but it does not provide new financial or operational catalysts.

03

What to watch

Traders may want to check the June 22, 2026 proxy and the June 22 8-K for compensation details and any stated succession rationale, since this filing references them but does not restate specifics.

Relevance 6/10Novelty 5/10Timing: post-close filing, effective at Aug. 6 shareholder meeting

Background

NVE Corp filed an 8-K covering director elections and executive appointments following its 2026 Annual Meeting of Shareholders on Aug. 6, 2026.

Company-level read

Ticker impact

$NVECNeutralMedium confidence
Context

NVE Corp disclosed CEO succession at its Aug. 6 shareholder meeting, with Daniel A. Baker retiring and Peter G. Eames appointed CEO.

Expected impact

Likely modest, sentiment-driven reaction around governance and leadership transition, with follow-through depending on any later strategy updates.

Evidence & confidence

The 8-K is a primary disclosure of leadership changes and director elections, but it does not include new earnings, contracts, or quantified performance changes.

Market effects

Limited direct sector read-through because the filing is company-specific governance and officer appointments.

No clear regional spillover beyond US-listed small/mid-cap sentiment.

Minimal global relevance; no international operations or cross-border deal disclosed.

Counterpoint

Leadership transitions can be a proxy for underlying performance issues; without context on why Baker retired, the market could interpret the change as corrective rather than routine.

Key entities

  • NVE Corp

    NASDAQ-listed company filing Form 8-K for director elections and officer appointments.

  • Daniel A. Baker

    Retired as president and CEO effective at the Aug. 6 shareholder meeting; re-elected and named chairman.

  • Peter G. Eames

    Elected to the board and appointed president and CEO.

  • Carolyn W. Valentine

    Elected to the board for the first time and appointed to Compensation and Nominating/Corporate Governance committees.

  • Boulay PLLP

    Ratified as independent registered public accounting firm for fiscal year ending March 31, 2027.

Related articles

$NVECHigh

NVE (NVEC) Q2 2027 Earnings Call Transcript

NVE (NVEC) reported Q2 2027 earnings with revenue of $16.9M, up 36% YoY. Net income was $3.17M or $0.65 per diluted share. The company expects medical and defense sales to recover and revenues in H2 to match H1. Operating expenses increased 4% YoY, with a 44% rise in SG&A and a 17% drop in R&D. The effective tax rate decreased to 14% due to favorable tax law changes. NVE announced new products in sensors and gear sensors, focusing on automation and robotics.

$NVECMed

NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend EDEN PRAIRIE, Minn.—October 21, 2026—NVE Corporation (Nasdaq: NVEC) announced financial results today for the quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 decr

$NVECMed

NVE (NVEC) Q1 2027 Earnings Call Transcript

NVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.

$NVECMed

NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result

$MRKMed

Merck to build molybdenum production facility in North Chungcheong, boosting supply of next-generation semiconductor materials

Merck will build a molybdenum production facility in Eumseong, South Korea, to support next-gen semiconductor materials. The company aims to integrate local production with supply systems to meet customer needs. Merck forecasts growing demand for molybdenum in semiconductor manufacturing, though adoption rates may vary. The facility will produce specialty precursors for CVD and ALD processes, with a focus on mass production and stable supply.